Marguerite Evans-Galea
#184,941
Most Influential Person Now
Australian geneticist
Marguerite Evans-Galea's AcademicInfluence.com Rankings
Marguerite Evans-Galeabiology Degrees
Biology
#16018
World Rank
#20120
Historical Rank
Genetics
#1980
World Rank
#2105
Historical Rank
Molecular Biology
#2861
World Rank
#2909
Historical Rank

Download Badge
Biology
Marguerite Evans-Galea's Degrees
- Bachelors Genetics University of Melbourne
- PhD Genetics University of Melbourne
Why Is Marguerite Evans-Galea Influential?
(Suggest an Edit or Addition)According to Wikipedia, Marguerite Virginia Evans-Galea is the co-founder of Women in STEMM Australia. STEMM . Her research is focused on gene therapy and neurodegenerative diseases. Early life and education Evans-Galea grew up in Mackay, Queensland. She was raised by her mother after her parents separated. In High School she learned clarinet and discovered classical music. After school she planned to be a music therapist, but she was "bitten by the science bug" in her third year of university.
Marguerite Evans-Galea's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- FXN methylation predicts expression and clinical outcome in Friedreich ataxia (2012) (114)
- Generation of Induced Pluripotent Stem Cell Lines from Friedreich Ataxia Patients (2011) (111)
- Compound heterozygous FXN mutations and clinical outcome in friedreich ataxia (2016) (99)
- An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels (2015) (77)
- Suppression of clonal dominance in cultured human lymphoid cells by addition of the cHS4 insulator to a lentiviral vector. (2007) (77)
- An experimental system for the evaluation of retroviral vector design to diminish the risk for proto-oncogene activation. (2008) (74)
- Mapping the DNA Binding Domain of the Zap1 Zinc-responsive Transcriptional Activator* (2000) (54)
- Epigenetic modifications in trinucleotide repeat diseases. (2013) (46)
- Zinc-Regulated DNA Binding of the Yeast Zap1 Zinc-Responsive Activator (2011) (35)
- Two of the five zinc fingers in the Zap1 transcription factor DNA binding domain dominate site-specific DNA binding. (2003) (33)
- Cell and gene therapy for Friedreich ataxia: progress to date. (2014) (28)
- A chromatin insulator blocks interactions between globin regulatory elements and cellular promoters in erythroid cells. (2007) (27)
- Friedreich's ataxia induced pluripotent stem cell-derived cardiomyocytes display electrophysiological abnormalities and calcium handling deficiency (2017) (26)
- Beyond loss of frataxin: the complex molecular pathology of Friedreich ataxia. (2014) (21)
- A novel deletion–insertion mutation identified in exon 3 of FXN in two siblings with a severe Friedreich ataxia phenotype (2011) (20)
- HFE p.C282Y heterozygosity is associated with earlier disease onset in Friedreich ataxia (2014) (9)
- Characterising the neuropathology and neurobehavioural phenotype in Friedreich ataxia: a systematic review. (2012) (7)
- T.P.15 An open label clinical pilot study of resveratrol as a treatment for Friedreich ataxia (2012) (3)
- diminish the risk for proto-oncogene activation An experimental system for the evaluation of retroviral vector design to (2009) (2)
- Developing Lentiviral Vectors for Gene Therapy of Wiskott-Aldrich Syndrome. (2004) (0)
- DEVELOPING CELL AND GENE THERAPY TO TREAT FRIEDREICH ATAXIA (2018) (0)
- The value of mentoring (2014) (0)
- 395. Developing Bone Marrow Transplant and Lentiviral Vectors for Friedreich Ataxia (2015) (0)
- Your science career: Making a strategic plan (2015) (0)
- 68. Evidence for Correction of Mutations in the c-Kit Gene by rAAV Mediated Gene Targeting in W/Wv Mice (2006) (0)
- Careers: Shaping our science future (2014) (0)
- 831. Evaluation of Lentiviral Vectors for Gene Therapy of Wiskott-Aldrich Syndrome (2005) (0)
- 179. Oncoretroviral Vector-Mediated Gene Therapy for Murine WAS Fails to Correct Most of the Deficient Biological Responses to S. pneumonia or M. bovis (2004) (0)
- Women in science: Closing the gender gap (2014) (0)
This paper list is powered by the following services:
Other Resources About Marguerite Evans-Galea
What Schools Are Affiliated With Marguerite Evans-Galea?
Marguerite Evans-Galea is affiliated with the following schools: